Alterations in Extracellular and Tissue Levels of Biogenic Amines in Rat Brain Induced by the Serotonin2Receptor Antagonist, Ritanserin
- 1 October 1992
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 59 (4) , 1459-1466
- https://doi.org/10.1111/j.1471-4159.1992.tb08461.x
Abstract
Systemic administration of ritanserin elicited rapid changes in dopamine (DA) and serotonin (5-HT) levels in both dialysate and neuronal tissue extracts. These effects occurred in both a site-selective and a dose-related manner. Increases in extracellular levels of DA and 5-HT in the nucleus accumbens were maximal at 120–140 min after treatment. A dose of 0.63 mgJ.kg of ritanserin elicited larger and more prolonged increases in extracellular DA and 5-HT levels than did the 0.3 mgJ.kg dose. By contrast, 0.63 mgJ.kg of ritanserin elicited no changes in either DA or 5-HT levels with dialysate collected from the striatum. Ritanserin also induced dose-related decreases in tissue levels of DA and 5-HT from the nucleus accumbens. The site specificity of action was again noted in that there were no dose-dependent decreases in tissue levels of DA or 5-HT measured from the striatum. Ritanserin exerted little effect on metabolite levels from either dialysate or tissue extracts. Taken together, these findings show that selective 5-HT2 receptor antagonism modulates DA and 5-HT neurotrans-mission in a specific manner. These actions appear to involve increased release of DA and 5-HT rather than significant changes in metabolism. These findings add further weight to the importance of 5-HT2 receptor interactions as an important component of antipsychotic activity.Keywords
This publication has 26 references indexed in Scilit:
- Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbensEuropean Journal of Pharmacology, 1991
- Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious ratsBritish Journal of Pharmacology, 1990
- Thymosthenic Agents, A Novel Approach in the Treatment of SchizophreniaThe British Journal of Psychiatry, 1989
- Brain MicrodialysisJournal of Neurochemistry, 1989
- Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the ratBiological Psychiatry, 1989
- Pharmacological profile of ritanserin: A very specific central serotonin S2-antagonistDrug Development Research, 1988
- Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: Increase in extracellular dopamine and serotoninBrain Research Bulletin, 1987
- Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivoNeuroscience Letters, 1987
- Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 2. In vitro profileDrug Development Research, 1987
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976